High Hopes for New Osteoporosis Drugs, but “Treatment Gap” Needs to Be Addressed


3 price-band (bracket) grouping rule:

The Column

Ask a Question and Shut Up


Evaluation of Efficacy Was Challenging in Sakigake Pick, Designating All Qualified Drugs Desirable: MHLW Official(Nov.27)
Viekirax Hits Japan Market, MHLW Orders Rare Label Revision upon Listing(Nov.27)
New Dosage Form of Ciproxan, Other Products with Minor Changes to Join NHI Price List on Nov. 28(Nov.27)
Eisai to Sell Food & Chemical Biz to Mitsubishi Chemical(Nov.27)
MHLW Allows Shipment of Kaketsuken DTP-IPV Vaccine(Nov.27)

News Calendar